![]() |
市場調查報告書
商品編碼
2059058
低FODMAP食品市場預測至2034年-按產品類型、成分改良類型、功能、消費模式和最終用戶分類的全球分析Low-FODMAP Diet Foods Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Modification Type, Functional Focus, Consumption Format, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球低 FODMAP 食品市場規模將達到 64 億美元,並在預測期內以 10.4% 的複合年成長率成長,到 2034 年將達到 141 億美元。
低FODMAP飲食食品旨在最大程度地減少可發酵碳水化合物,這些碳水化合物會引起大腸激躁症(IBS)患者或消化器官系統敏感族群的消化器官系統不適。 FODMAP包括某些醣類和纖維,它們會導致腹脹、脹氣、胃痛和消化器官系統。這類食品去除或限制了小麥、洋蔥、大蒜和某些乳製品等成分,同時保持營養均衡和偏好。產品類型包括零食、醬料、烘焙食品、乳製品替代品和調理食品。人們對消化健康和個人化營養的日益關注正在推動對低FODMAP飲食解決方案的需求。
大腸激躁症病例增加
消費者越來越重視透過飲食來管理消化器官系統問題。醫療保健專業人員也開始將低FODMAP飲食納入治療方案。預防醫學的發展趨勢推動了特殊食品的普及。食品公司正致力於開發低FODMAP配方以滿足這一需求。消化健康的知識正透過網路社群和健康宣傳宣傳活動不斷傳播。
原料採購選擇有限
特殊配方需要精心挑選符合特定標準的原料。製造商在保持全線產品品質一致性方面面臨挑戰。有限的供應鏈推高了生產成本。原料供應的區域差異限制了企業規模。中小企業在原物料採購方面難以與大型企業競爭。儘管市場需求不斷成長,但這些因素阻礙了企業滲透市場。
調理食品食品的擴張
快節奏的生活方式推動了人們對便捷易消化食品的需求。調理食品減輕了腸躁症(IBS)患者的飲食準備負擔。口味和包裝的創新提升了消費者的興趣。價格親民的產品能夠吸引更廣泛的消費者,而不僅限於注重健康的特定群體。與醫療保健專業人士的合作則能增強品牌信譽。預計這一機遇將推動產品多樣化的快速成長。
長期飲食療法永續性的局限性
低FODMAP飲食長期堅持率低是市場面臨的一大挑戰。許多消費者難以長期堅持嚴格的飲食限制。味覺疲勞和食物選擇有限會降低永續性。社會和文化飲食習慣往往與飲食指南相衝突。短期實踐者的退出率仍然很高。媒體對低FODMAP飲食永續性的負面通報會削弱消費者的信心。
新冠疫情對低FODMAP食品市場產生了複雜的影響。一方面,由於疫情封鎖期間消費者更加重視免疫力和消化健康,需求增加,線上銷售管道也顯著擴張。另一方面,供應鏈中斷影響了原料的供應。經濟的不確定性限制了部分地區奢侈品的購買。人們對預防醫學的認知不斷提高,促使更多人選擇有益於消化的食品。
在預測期內,低乳糖產品細分市場預計將佔據最大的市場佔有率。
隨著消費者越來越將減少乳糖攝取與消化舒適聯繫起來,預計在預測期內,低乳糖產品細分市場將佔據最大的市場佔有率。無乳糖牛奶、優格和起司在零售店和線上通路廣受歡迎。製造商正加大對口味創新的投入,以提升產品的市場接受度。在已開發市場,低乳糖產品在零售市場正日益受到青睞。注重預防保健的人更傾向於選擇無乳糖產品來維持日常健康。價格實惠的產品也深受廣大消費者的歡迎。
在預測期內,食材自煮包和已調理食品細分市場預計將呈現最高的複合年成長率。
在預測期內,由於消費者對便利飲食解決方案的需求不斷成長,食材自煮包和已調理食品領域預計將呈現最高的成長率。患有大腸激躁症(IBS) 的消費者更傾向於選擇即食產品,因為這樣更容易堅持他們的飲食計劃。符合低 FODMAP 飲食指南的食材自煮包創新產品正在推動其流行。尤其年輕一代更青睞健康便捷的膳食。數位平台也有助於提高人們對易消化食材自煮包的認知度。醫療保健專業人員也擴大推薦已調理食品用於膳食管理。
在預測期內,由於歐洲地區對消化器官系統健康管理的重視,預計該地區將佔據最大的市場佔有率。歐洲市場擁有完善的法規結構,支持特殊飲食領域的創新。許多大型企業和研究機構的總部都設在該地區。預防性醫療保健的理念已在消費者中根深蒂固。低FODMAP產品在德國、法國和英國等國的零售市場越來越受歡迎。醫療保健專業人員也積極推薦腸躁症(IBS)患者的飲食方案。歐洲將繼續成為全球整體銷售額的最大貢獻者。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於可支配收入的成長和健康意識的提高。中國、印度和東南亞的都市區正迅速接受低FODMAP飲食。電子商務調理食品正在協助消化器官系統友善產品的分銷。文明病的日益增加推動了人們對預防性營養的需求。價格實惠的即食食品越來越受到一般消費者的歡迎。年輕一代正在擁抱整體健康的飲食習慣。
According to Stratistics MRC, the Global Low-FODMAP Diet Foods Market is accounted for $6.4 billion in 2026 and is expected to reach $14.1 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Low-FODMAP diet foods are products formulated to minimize fermentable carbohydrates that can trigger digestive discomfort in individuals with irritable bowel syndrome (IBS) or sensitive digestive systems. FODMAPs include certain sugars and fibers that may cause bloating, gas, abdominal pain, and digestive irregularities. These foods exclude or limit ingredients such as wheat, onions, garlic, and certain dairy products while maintaining nutritional balance and palatability. Product categories include snacks, sauces, bakery products, dairy alternatives, and ready meals. Growing awareness of digestive health and personalized nutrition is driving demand for low-FODMAP dietary solutions.
Rising irritable bowel syndrome cases
Consumers are becoming more aware of dietary interventions to manage digestive discomfort. Healthcare providers are recommending low-FODMAP diets as part of treatment plans. Preventive health trends are encouraging adoption of specialized foods. Food companies are innovating with low-FODMAP formulations to meet this demand. Online communities and wellness campaigns are spreading knowledge about digestive health.
Limited ingredient sourcing options
Specialized formulations require careful selection of compliant raw materials. Manufacturers face challenges in maintaining consistency across product lines. Limited supply chains increase production costs. Regional variations in ingredient availability restrict scalability. Smaller companies struggle to compete with larger players in sourcing. This factor slows down market penetration despite rising demand.
Expansion in ready-meal products
Busy lifestyles are driving demand for convenient, digestive-friendly options. Ready meals reduce the burden of meal preparation for IBS patients. Innovation in flavors and packaging enhances consumer appeal. Affordable offerings can attract mainstream buyers beyond niche health groups. Partnerships with healthcare providers expand credibility. This opportunity is expected to drive rapid growth in product diversification.
Limited long-term dietary adherence
The market faces a threat from limited long-term adherence to low-FODMAP diets. Many consumers struggle to maintain strict dietary restrictions over time. Taste fatigue and limited food choices reduce sustainability. Social and cultural eating habits often conflict with diet guidelines. Dropout rates remain high among casual adopters. Negative publicity around diet sustainability can reduce consumer confidence.
Covid-19 had a mixed impact on the low-FODMAP diet foods market. On one hand, demand rose as consumers focused on immunity and digestive health during lockdowns. Online sales channels grew significantly. On the other hand, supply chain disruptions affected ingredient availability. Economic uncertainty limited premium purchases in some regions. Preventive health awareness increased adoption of digestive-friendly foods.
The lactose-reduced products segment is expected to be the largest during the forecast period
The lactose-reduced products segment is expected to account for the largest market share during the forecast period as onsumers increasingly associate lactose reduction with digestive relief. Lactose-free milk, yogurt, and cheese are widely adopted across retail and online channels. Manufacturers are investing in flavor innovation to improve acceptance. Retail penetration of lactose-reduced products is strong in developed markets. Preventive health seekers prefer lactose-free options for daily wellness routines. Affordable offerings appeal to mass consumers.
The meal kits & prepared meals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the meal kits & prepared meals segment is predicted to witness the highest growth rate due to rising demand for convenient dietary solutions. Consumers with IBS prefer ready-to-eat options that simplify adherence. Innovation in meal kits tailored to low-FODMAP guidelines supports adoption. Younger demographics are particularly inclined toward convenient health-focused meals. Digital platforms promote awareness of digestive-friendly meal kits. Healthcare providers are increasingly recommending prepared meals for dietary management.
During the forecast period, the Europe region is expected to hold the largest market share owing to established digestive health adoption. European markets have advanced regulatory frameworks supporting specialized diet innovation. Leading companies and research institutions are headquartered in this region. Preventive health trends are well established among consumers. Retail penetration of low-FODMAP products is strong in countries such as Germany, France, and the UK. Healthcare providers actively promote dietary interventions for IBS. Europe will remain the largest contributor to global revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising disposable incomes and growing health consciousness. Urban populations in China, India, and Southeast Asia are adopting low-FODMAP diets rapidly. E-commerce platforms support distribution of digestive-friendly products. Lifestyle-related diseases are increasing, fueling demand for preventive nutrition. Affordable ready-meal options appeal to mass consumers. Younger demographics are embracing holistic diets.
Key players in the market
Some of the key players in Low-FODMAP Diet Foods Market include Nestle S.A., Danone S.A., General Mills, Inc., Kellogg Company, The Hain Celestial Group, Inc., Monash University, FODY Foods Co., Rachel Pauls Food, BelliWelli, Gourmend Foods, Casa de Sante, Naturally Nourished Inc., FODMAP Friendly Pty Ltd, Glanbia plc and Arla Foods amba.
In May 2026, Nestle announced it is expanding the scope of its "Strategic Growth Platforms" from 10% to 30% of total sales to accelerate real internal growth. This collaborative realignment prioritizes high-growth categories like "Consumer Health" and "Medical Nutrition," providing the capital needed to scale the company's low-FODMAP and GI-targeted portfolio across its global distribution network through 2030.
In January 2026, Monash University expanded its strategic partnership with global dietetic associations to launch an updated 10-module online certification for health professionals. This collaborative initiative synthesizes the latest clinical findings to standardize the implementation of low-FODMAP protocols, ensuring that 2026's "Gut-Health" practitioners can provide evidence-based guidance to the estimated 10% of the global population suffering from IBS.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.